Which medicines have been fully exempted from customs duty in Budget 2025?

Some medicines exempted from customs duty are asciminib, mepolizumab, daratumumab, daratumumab subcutaneous, teclistamab, amivantamab, alectinib, risdiplam and obinutuzumab. Entrectinib, spesolimab, idursulphatase, laronidase, tepotinib, miglustat, alirocumab, evolocumab, inclisiran, velmanase alfa have also been exempted. The list also includes imiglucerase and cystamine bitartrate.